AMGN vs ECL · P/E 24, rev $36.75B vs P/E 35, rev $4.01B
Amgen Inc (AMGN) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the AMGN and ECL stock pages for the full models.
Not investment advice.